Trial: 202103080

A Phase 3, Randomized, Double-Blind, Adaptive, Placebo/Paclitaxel-Controlled Study of AVB-S6-500 in Combination with Paclitaxel in Patients with Platinum-Resistant Recurrent Ovarian Cancer

Phase

III (Cancer Control)

Principal Investigator

Thaker, Premal

Disease Site

Ovary

Learn more about this study at: clinicaltrials.gov